S.C. Ropharma Balance Sheet Health
Financial Health criteria checks 6/6
S.C. Ropharma has a total shareholder equity of RON253.0M and total debt of RON68.1M, which brings its debt-to-equity ratio to 26.9%. Its total assets and total liabilities are RON885.3M and RON632.4M respectively. S.C. Ropharma's EBIT is RON21.1M making its interest coverage ratio 3.6. It has cash and short-term investments of RON32.5M.
Key information
26.9%
Debt to equity ratio
RON 68.09m
Debt
| Interest coverage ratio | 3.6x |
| Cash | RON 32.48m |
| Equity | RON 252.99m |
| Total liabilities | RON 632.36m |
| Total assets | RON 885.35m |
Recent financial health updates
Is S.C. Ropharma (BVB:RPH) Using Too Much Debt?
Jun 01
S.C. Ropharma (BVB:RPH) Takes On Some Risk With Its Use Of Debt
May 15Recent updates
Here's What's Concerning About S.C. Ropharma's (BVB:RPH) Returns On Capital
Dec 09S.C. Ropharma (BVB:RPH) Is Reinvesting At Lower Rates Of Return
Sep 23Is S.C. Ropharma (BVB:RPH) Using Too Much Debt?
Jun 01Some Investors May Be Worried About S.C. Ropharma's (BVB:RPH) Returns On Capital
Mar 16S.C. Ropharma (BVB:RPH) Takes On Some Risk With Its Use Of Debt
May 15S.C. Ropharma (BVB:RPH) Might Be Having Difficulty Using Its Capital Effectively
Mar 26Should You Be Impressed By S.C. Ropharma's (BVB:RPH) Returns on Capital?
Dec 23
We Wouldn't Rely On S.C. Ropharma's (BVB:RPH) Statutory Earnings As A Guide
Nov 24Financial Position Analysis
Short Term Liabilities: RPH's short term assets (RON526.5M) exceed its short term liabilities (RON520.1M).
Long Term Liabilities: RPH's short term assets (RON526.5M) exceed its long term liabilities (RON112.3M).
Debt to Equity History and Analysis
Debt Level: RPH's net debt to equity ratio (14.1%) is considered satisfactory.
Reducing Debt: RPH's debt to equity ratio has reduced from 40.3% to 26.9% over the past 5 years.
Debt Coverage: RPH's debt is well covered by operating cash flow (66.1%).
Interest Coverage: RPH's interest payments on its debt are well covered by EBIT (3.6x coverage).